Inventor
SCHMITT URBAN
DE32 patents
⚠️ This page may combine multiple inventors who share the name “SCHMITT URBAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE DIAGNOSTICS GMBH
13 patentsUS6187270B1Feb 13, 2001
Device and method for the separation of magnetic microparticles
ROCHE DIAGNOSTICS GMBH120 citations96
US6645732B2Nov 11, 2003
Antigen-specific IgG detection
ROCHE DIAGNOSTICS GMBH45 citations92
US6306579B1Oct 23, 2001
Recombinant antigen from the NS3 region of the hepatitis C virus
ROCHE DIAGNOSTICS GMBH24 citations92
US6096319AAug 1, 2000
Recombinant antigen from the NS3 region of the hepatitis C virus
ROCHE DIAGNOSTICS GMBH19 citations92
US5965378AOct 12, 1999
Antibody class-specific interference eliminating reagent
ROCHE DIAGNOSTICS GMBH23 citations92
US6312916B1Nov 6, 2001
Recombinant inactive core streptavidin mutants
ROCHE DIAGNOSTICS GMBH38 citations91
US6489129B1Dec 3, 2002
Antigen-specific IgM detection
ROCHE DIAGNOSTICS GMBH41 citations89
US6391571B1May 21, 2002
Recombinant inactive avidin mutants
ROCHE DIAGNOSTICS GMBH15 citations83
US6270960B1Aug 7, 2001
Recombinant antigen from the NS3 region of the hepatitis C virus
ROCHE DIAGNOSTICS GMBH5 citations73
US6417331B1Jul 9, 2002
Recombinant inactive core streptavidin mutants
ROCHE DIAGNOSTICS GMBH12 citations70
US7122302B2Oct 17, 2006
Method for determining early HCV seroconversion
ROCHE DIAGNOSTICS GMBH1 citations62
US5998157ADec 7, 1999
Acylated protein aggregates and their use as signal enhancers in an immunoassay for the detection of antibodies
ROCHE DIAGNOSTICS GMBH0 citations51
US6447992B1Sep 10, 2002
Method for serological typing using type-specific antigens
ROCHE DIAGNOSTICS GMBH0 citations47
BOEHRINGER MANNHEIM GMBH
9 patentsUS5804371ASep 8, 1998
Hapten-labelled peptides
BOEHRINGER MANNHEIM GMBH32 citations92
US5804391ASep 8, 1998
Elimination of rheumatoid factor interference using anti-FD antibodies
BOEHRINGER MANNHEIM GMBH33 citations91
US5376557ADec 27, 1994
Process for the determination of antibodies which are class-specific for an antigen and a reagent for carrying out the process
BOEHRINGER MANNHEIM GMBH8 citations74
US4695552ASep 22, 1987
Process and reagent for the determination of the hemoglobin-haptoglobin complex in the presence of free hemoglobin
BOEHRINGER MANNHEIM GMBH10 citations73
US4438204AMar 20, 1984
Determination of glycosilated hemoglobin
BOEHRINGER MANNHEIM GMBH15 citations73
US5776702AJul 7, 1998
Process for the determination of an immunologically detectable substance and a suitable reaction vessel therefor
BOEHRINGER MANNHEIM GMBH8 citations72
US5362624ANov 8, 1994
Process for the determination of an immunologically detectable substance and a suitable reaction vessel therefor
BOEHRINGER MANNHEIM GMBH8 citations72
US5277589AJan 11, 1994
Process for the determination of antibodies
BOEHRINGER MANNHEIM GMBH9 citations71
US5935778AAug 10, 1999
Method for serological typing using type-specific antigens
BOEHRINGER MANNHEIM GMBH3 citations57
SCHOLZ CHRISTIAN
4 patentsUS8790659B2Jul 29, 2014
SlpA as a tool for recombinant protein and enzyme technology
SCHOLZ CHRISTIAN0 citations50
US8263086B2Sep 11, 2012
SlpA as a tool for recombinant protein and enzyme technology
SCHOLZ CHRISTIAN0 citations50
US8247206B2Aug 21, 2012
Fusion protein comprising an Escherichia coli chaperone protein and a human chaperone protein
SCHOLZ CHRISTIAN0 citations50
US8426167B2Apr 23, 2013
Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides
SCHOLZ CHRISTIAN0 citations49
ROCHE DIAGNOSTICS OPERATIONS
3 patentsUS7244819B2Jul 17, 2007
Fusion polypeptides, vaccines and compositions of FKBP chaperones and target polypeptides
ROCHE DIAGNOSTICS OPERATIONS19 citations91
US9316642B2Apr 19, 2016
Soluble immunoreactive treponema pallidum TpN47 antigens
ROCHE DIAGNOSTICS OPERATIONS0 citations51
US7947494B2May 24, 2011
Fusion protein comprising an E. coli chaperone protein and a human chaperone protein
ROCHE DIAGNOSTICS OPERATIONS0 citations51
ROCHE DIAGNOSTICS OPERATIONS INC
2 patentsUS9714949B2Jul 25, 2017
Vibrio cholerae lipoprotein 15 (Lp15) variants as anti-interference additive in TpN17-based immunoassays for detection of anti-Treponema antibodies
ROCHE DIAGNOSTICS OPERATIONS INC0 citations51
US10197559B2Feb 5, 2019
Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
ROCHE DIAGNOSTICS OPERATIONS INC0 citations50